Constantia-PatzConstantia-Flexibles

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's...

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group, have announced an option to license agreement to develop SIM0500, an investigational new drug...

Daiichi Sankyo Company will pay Glycotope $132.5 million to acquire intellectual property rights of the antitumor-associated mucin-1 (TA-MUC1) antibody, gatipotuzumab. Such payment by Daiichi Sankyo...